Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
Portfolio Pulse from Benzinga Insights
Unusual options activity has been observed for Regeneron Pharmaceuticals (NASDAQ:REGN), with a large position indicating a bullish stance. The sentiment among these big-money traders is split between 60% bullish and 40% bearish. The whales have been targeting a price range from $600.0 to $780.0 for Regeneron Pharmaceuticals over the last 3 months. The current price of REGN is down -1.31% at $695.57. Several experts have maintained their ratings on Regeneron Pharmaceuticals, with price targets ranging from $789 to $1045.
July 07, 2023 | 4:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regeneron Pharmaceuticals has seen unusual options activity, with a large position indicating a bullish stance. The current price of REGN is down -1.31% at $695.57. Several experts have maintained their ratings on Regeneron Pharmaceuticals, with price targets ranging from $789 to $1045.
The unusual options activity, particularly the large bullish position, indicates that there may be significant movement in the stock price of Regeneron Pharmaceuticals in the near future. The current price is down, but the price targets set by experts suggest potential for growth. Therefore, the impact on the stock price is likely to be positive in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100